Symposium:
167. New Guidelines and Recommendations for Tropical Diseases in the United States
Friday, October 9, 2015: 2:00 PM-3:30 PM
Room: 6--CF
Co-organized with the IDSA-ASTMH Guidelines Panel

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • summarize IDSA and ASTMH joint guidelines
  • discuss the current approaches to managing patients
  • describe the current approaches to managing patients with all forms of cysticercosis

Target Audience: Vaccinologists, Scientists, Researchers, Public health practitioners, Pharmacists, Nurses, Microbiologists, Members-in-training, Lab personnel, Investigators, Infectious diseases physicians, Infectious diseases pediatricians, Healthcare workers, Fellows, Epidemiologists, Clinicians, Academicians

Tracks: Trainee, Pediatric ID, Investigative ID, Global ID, Adult ID

Moderator:  Joseph Vinetz, MD, FIDSA, University of California San Diego

Presentations:
2:00 PM
1249
IDSA-ASTMH Clinical Practice Guideline for Leishmaniasis
Naomi Aronson, MD, FIDSA
2:45 PM
1250
Guidelines for Management of Neurocysticercosis
A. Clinton White, MD, FIDSA

CME Credits: Maximum of 1.5 hours of AMA PRA Category 1 CreditTM

ACPE Credits: ACPE 1.5 knowledge-based contact hours (0.15 CEU) of pharmacy CE

ACPE Number: 0221-9999-15-181-L01-P

Disclosures:

J. Vinetz, None

See more of: Symposium
<< Previous Session | Next Session >>

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 7th with the exception of research findings presented at the IDWeek press conferences.